FDA leadership crisis reveals systemic governance and regulatory challenges
Original framing: “STAT+: Why Marty Makary was the worst FDA commissioner in 25 years” — STAT News
Scientific integrity in regulatory bodies is crucial for public health. Makary’s tenure raises concerns about the separation of scientific evidence from political influence, a principle central to effective drug regulation.
Marty Makary’s resignation from the FDA is not an isolated incident but a symptom of systemic governance failures in public health.
The tension between political influence and scientific integrity is exacerbated by a lack of transparency and community inclusion in regulatory processes. By examining historical precedents, cross-cultural regulatory models, and the voices of marginalized communities, we can begin to reform institutions that serve not just industry interests, but the health of all people. Integrating scientific rigor with ethical governance and public participation is essential to restoring trust and ensuring equitable health outcomes.